Author: Sophia Vida

The FDA has approved a gene therapy treatment for use in the U.S to Novartis Pharmaceuticals Corp. that may give many young patients with leukemia hope. The treatment is a procedure called Kymriah (tisagenlecleucel) that uses a patient’s own cells to combat a particular type of leukemia. The FDA has approved it to be used … Continue reading “The First FDA Approved Therapy to Fight Leukemia is Here”